Background: Endoscopic gastroduodenal stent (GDS) placement is widely used as a safe and effective method to rapidly improve gastrointestinal symptoms of malignant gastric outlet obstruction (MGOO). While previous studies reported the utility of chemotherapy after GDS placement for prognosis improvement, they did not fully address the issue of immortal time bias.

Objectives: To examine the association between prognosis and clinical course following endoscopic GDS placement, using a time-dependent analysis.

Design: Multicenter retrospective cohort study.

Methods: This study included 216 MGOO patients who underwent GDS placement between April 2010 and August 2020. Data of patient baseline characteristics, including age, gender, cancer type, performance status (PS), GDS type and length, GDS placement location, gastric outlet obstruction scoring system (GOOSS) score, and history of chemotherapy before GDS were collected. The clinical course following GDS placement was evaluated by GOOSS score, stent dysfunction, cholangitis, and chemotherapy. A Cox proportional hazards model was used to identify prognostic factors after GDS placement. Stent dysfunction, post-stent cholangitis, and post-stent chemotherapy were analyzed as time-dependent covariates.

Results: Mean GOOSS scores before and after GDS were 0.7 and 2.4, respectively, with significant improvement after GDS placement ( < 0.001). The median survival time after GDS placement was 79 [95% confidence interval (CI): 68-103] days. In multivariate Cox proportional hazards model with time-dependent covariates, PS 0-1 [hazard ratio (HR): 0.55, 95% CI: 0.40-0.75;  < 0.001], ascites (HR: 1.45, 95% CI: 1.04-2.01;  = 0.028), metastasis (HR: 1.84, 95% CI: 1.31-2.58;  < 0.001), post-stent cholangitis (HR: 2.38, 95% CI: 1.37-4.15;  = 0.002), and post-stent chemotherapy (HR: 0.01, 95% CI: 0.002-0.10;  < 0.001) significantly affected prognosis after GDS placement.

Conclusion: Post-stent cholangitis and tolerability to receive chemotherapy after GDS placement influenced prognosis in MGOO patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989375PMC
http://dx.doi.org/10.1177/17562848231156279DOI Listing

Publication Analysis

Top Keywords

gds placement
32
gastric outlet
12
outlet obstruction
12
gds
11
placement
9
endoscopic gastroduodenal
8
gastroduodenal stent
8
malignant gastric
8
multicenter retrospective
8
retrospective cohort
8

Similar Publications

Objective: There have been few studies predicting institutionalization or death in home care settings. We examined risk factors for nursing home placement (NHP) and death among home care patients.

Design: A prospective one-year follow-up study.

View Article and Find Full Text PDF

This study describes two novel species of marine dinophytes in the genus Alexandrium. Morphological characteristics and phylogenetic analyses support the placement of the new taxa, herein designated as Alexandrium limii sp. nov.

View Article and Find Full Text PDF

Background: Endoscopic gastroduodenal stent (GDS) placement is widely used as a safe and effective method to rapidly improve gastrointestinal symptoms of malignant gastric outlet obstruction (MGOO). While previous studies reported the utility of chemotherapy after GDS placement for prognosis improvement, they did not fully address the issue of immortal time bias.

Objectives: To examine the association between prognosis and clinical course following endoscopic GDS placement, using a time-dependent analysis.

View Article and Find Full Text PDF

Base editor scanning charts the DNMT3A activity landscape.

Nat Chem Biol

February 2023

Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.

DNA methylation is critical for regulating gene expression, necessitating its accurate placement by enzymes such as the DNA methyltransferase DNMT3A. Dysregulation of this process is known to cause aberrant development and oncogenesis, yet how DNMT3A is regulated holistically by its three domains remains challenging to study. Here, we integrate base editing with a DNA methylation reporter to perform in situ mutational scanning of DNMT3A in cells.

View Article and Find Full Text PDF

Background: Cardiac resynchronization therapy (CRT) has been demonstrated to improve heart failure (HF) symptoms, reverse LV remodeling, and reduce mortality and HF hospitalization (HFH) in patients with a reduced left ventricular (LV) ejection fraction (LVEF). Prior studies examining outcomes based on right ventricular (RV) lead position among CRT patients have provided mixed results. We performed a systematic review and meta-analysis of randomized controlled trials and prospective observational studies comparing RV apical (RVA) and non-apical (RVNA) lead position in CRT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!